Altered CD4 interactions of HIV type 1 LAI variants selected for the capacity to induce membrane fusion in the presence of a monoclonal antibody to domain 2 of CD4

被引:6
作者
Klasse, PJ
Sattentau, QJ
机构
[1] INST CANC RES,CHESTER BEATTY LABS,LONDON SW3 6JB,ENGLAND
[2] CTR IMMUNOL MARSEILLE LUMINY,F-13288 MARSEILLE,FRANCE
关键词
D O I
10.1089/aid.1996.12.1015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We selected HIV-1-LAI variants with the ability to induce syncytium formation of C8166 cells in the presence of a monoclonal antibody (MAb), 5A8, to domain 2 of CD4, Five biologically cloned variants with at least 60-fold greater resistance than wild type to 5A8-mediated inhibition of syncytium formation were obtained, The variants exhibited reduced relative sensitivity to inhibition of syncytium formation and virus infection, not only by the selecting anti-domain 2 MAb, but also by MAbs to domains 1 and 3 of CD4, By contrast, the sensitivity of these variants to neutralization by soluble CD4 and bivalent CD4-lgG was greater than for the parental clone, The affinities of soluble CD4 for Env protein, in either solubilized or membrane-anchored form, did not differ significantly between the variants and LAI, Analyses of sCD4-induced exposure of the transmembrane protein at 4 and 37 degrees C suggested, however, that the variants had acquired an increased susceptibility to the triggering of conformational changes in their Env oligomers at 37 degrees C, This may represent a mechanism of both the increased resistance to the CD4 MAbs and the enhanced sensitivity to soluble CD4.
引用
收藏
页码:1015 / 1021
页数:7
相关论文
共 28 条
[1]  
BURKLY LC, 1992, J IMMUNOL, V149, P1779
[2]   BIOLOGICAL PROPERTIES OF A CD4 IMMUNOADHESIN [J].
BYRN, RA ;
MORDENTI, J ;
LUCAS, C ;
SMITH, D ;
MARSTERS, SA ;
JOHNSON, JS ;
COSSUM, P ;
CHAMOW, SM ;
WURM, FM ;
GREGORY, T ;
GROOPMAN, JE ;
CAPON, DJ .
NATURE, 1990, 344 (6267) :667-670
[3]   SPECIFIC CELL-SURFACE REQUIREMENTS FOR THE INFECTION OF CD4-POSITIVE CELLS BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 AND BY SIMIAN IMMUNODEFICIENCY VIRUS [J].
CLAPHAM, PR ;
BLANC, D ;
WEISS, RA .
VIROLOGY, 1991, 181 (02) :703-715
[4]   RAT MONOCLONAL-ANTIBODIES TO NONOVERLAPPING EPITOPES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 BLOCK CD4 BINDING INVITRO [J].
CORDELL, J ;
MOORE, JP ;
DEAN, CJ ;
KLASSE, PJ ;
WEISS, RA ;
MCKEATING, JA .
VIROLOGY, 1991, 185 (01) :72-79
[5]   HIV INFECTION IS BLOCKED INVITRO BY RECOMBINANT SOLUBLE CD4 [J].
FISHER, RA ;
BERTONIS, JM ;
MEIER, W ;
JOHNSON, VA ;
COSTOPOULOS, DS ;
LIU, T ;
TIZARD, R ;
WALKER, BD ;
HIRSCH, MS ;
SCHOOLEY, RT ;
FLAVELL, RA .
NATURE, 1988, 331 (6151) :76-78
[6]   GENERATION OF HUMAN MONOCLONAL-ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS [J].
GORNY, MK ;
GIANAKAKOS, V ;
SHARPE, S ;
ZOLLAPAZNER, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (05) :1624-1628
[7]   NOVEL ANTI-CD4 MONOCLONAL-ANTIBODIES SEPARATE HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND FUSION OF CD4+ CELLS FROM VIRUS BINDING [J].
HEALEY, D ;
DIANDA, L ;
MOORE, JP ;
MCDOUGAL, JS ;
MOORE, MJ ;
ESTESS, P ;
BUCK, D ;
KWONG, PD ;
BEVERLEY, PCL ;
SATTENTAU, QJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (04) :1233-1242
[8]   DIFFERENCES IN CD4 DEPENDENCE FOR INFECTIVITY OF LABORATORY-ADAPTED AND PRIMARY PATIENT ISOLATES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
KABAT, D ;
KOZAK, SL ;
WEHRLY, K ;
CHESEBRO, B .
JOURNAL OF VIROLOGY, 1994, 68 (04) :2570-2577
[9]   MORPHOMETRIC ANALYSIS OF RECOMBINANT SOLUBLE CD4-MEDIATED RELEASE OF THE ENVELOPE GLYCOPROTEIN GP120 FROM HIV-1 [J].
KIRSH, R ;
HART, TK ;
ELLENS, H ;
MILLER, J ;
PETTEWAY, SA ;
LAMBERT, DM ;
LEARY, J ;
BUGELSKI, PJ .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (10) :1209-1212
[10]   Quantitative model of antibody- and soluble CD4-mediated neutralization of primary isolates and T-cell line-adapted strains of human immunodeficiency virus type 1 [J].
Klasse, PJ ;
Moore, JP .
JOURNAL OF VIROLOGY, 1996, 70 (06) :3668-3677